Companies manufacturing cytotoxic drugs must ensure that staff are given the highest possible levels of protection.
Ian Samson
Advertisement
Ian Samson is DuPont consultant for the EMEA and Russia regions, www.chemicalprotection.dupont.co.uk.
Articles by Ian Samson
It is vital that companies involved in the manufacturing and handling of cytotoxic drugs ensure that staff are given the highest possible levels of protection.
Advertisement
Latest Updated Articles
- Considerations for personal protective equipment when handling cytotoxic drugs
Published: March 2nd 2015 | Updated:
- Choosing Personal Protective Equipment for Handling Cytotoxic Drugs
Published: April 8th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
4
How AI, Machine Learning, and Large Language Models Enhance Bioanalysis
5
